Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.

Burza, Sakib

Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India. [electronic resource] - PLoS neglected tropical diseases 2014 - e2536 p. digital

Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

1935-2735

10.1371/journal.pntd.0002536 doi


Administration, Intravenous
Adolescent
Adult
Aged
Aged, 80 and over
Amphotericin B--administration & dosage
Antiprotozoal Agents--administration & dosage
Child
Child, Preschool
Cohort Studies
Female
Humans
India--epidemiology
Infant
Leishmaniasis, Visceral--drug therapy
Male
Middle Aged
Recurrence
Retrospective Studies
Risk Factors
Young Adult